Abstract Deadline Extended

Deadline Extended

The organizers of the 5th International Conference on Advances in Hematology and Oncology have extended the deadline to submit abstracts for presentation. The new deadline is June 30th, 2017, 11:59 PM PST.

Abstracts relating to Oncology and Hematology can fall under the following categories: basic science research, clinical research, and case reports. Chosen abstracts will be published in the journal, Anticancer Research.

Abstracts should not have been previously published. Abstracts must be 300 words or less and should be written in English. All other policies for ICAHO 2017 abstract submissions can be found here.

For more information about ICAHO 2017, visit our website oncology.binayfoundation.org.

 

The ICAHO Abstract Merit Award Deadline is Approaching! Don’t miss out on your chance to present your abstract!

Merit Award Deadline 2

There are only ten days left until the deadline to submit abstracts eligible for the Merit Award for the 5th International Conference on Advances in Hematology and Oncology. We at BTF are excited to read your basic science and clinical research abstracts, as well as abstracts about case reports. All abstracts must be related to Oncology, Hematology, and/or Palliative Care.

Up to ten awards will be given to entrants for them to present their abstract at ICAHO 2017. Award recipients will receive $500.00 for travel assistance, as well as complimentary conference registration. Abstracts eligible for this award must have an applicant who is one of the following: a medical student, graduate student, resident physician, postdoctoral fellow (MD or PhD), or a junior faculty (in practice for less than three years). The applicant must also be the first or senior author of the abstract; this person will also be the presenter at the conference. Abstracts to be considered for an award must be submitted by May 15th, 2017, 11:59 PM PST.

Find out more about the abstract policy here. All abstracts must be submitted by June 16th, 2017, 11:59 PM PST. Accepted abstracts will be published in the journal, Anticancer Research. Email abstracts and a list of authors to hemeonc@binayfoundation.org.